摘要 |
The invention relates to a nucleic acid comprising a nucleotide sequence encoding a Parvoviral Rep protein, wherein a nuclear localization signal (NLS) in said Parvoviral Rep protein is mutated as compared with a corresponding wild type sequence. The invention also relates to a nucleic acid comprising a nucleotide sequence encoding a Parvoviral Rep protein, wherein the zinc finger domain in said Parvoviral Rep protein is mutated as compared with a corresponding wild type sequence. Further, the invention relates to a nucleic acid comprising a nucleotide sequence encoding a Parvoviral Rep protein, wherein an amino acid at position 43, 57, 79, 97, 120, 179, 305, 484, 493 or 571 of the said Parvoviral Rep protein is mutated in comparison to a corresponding wild type sequence, said amino acid position being defined with reference to SEQ ID NO: 2. |
申请人 |
AMSTERDAM MOLECULAR THERAPEUTICS (AMT) IP B.V.;NOORDMAN, YVET;LUBELSKI, JACEK;BAKKER, ANDREW CHRISTIAN |
发明人 |
NOORDMAN, YVET;LUBELSKI, JACEK;BAKKER, ANDREW CHRISTIAN |